申请人:Kakizuka Akira
公开号:US20130184241A1
公开(公告)日:2013-07-18
The present invention provides compounds which can regulate VCP activity. The present invention provides the compound of formula (I)
(R is as defined in the description)
or oxides, esters, prodrugs, pharmaceutically acceptable salts or solvates thereof. The compounds can regulate VCP activity, and thus are useful for treating VCP-mediated diseases such as neurodegenerative diseases.
本发明提供了可以调节VCP活性的化合物。本发明提供了式(I)的化合物(其中R如描述中所定义)或其氧化物、酯、前药、药学上可接受的盐或溶剂。这些化合物可以调节VCP活性,因此可用于治疗VCP介导的疾病,如神经退行性疾病。